Xintela

0.24 SEK

-2.83%

Less than 1K followers

XINT

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xintela

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)2.292.031.340.490.270.330.28
Shares71.9126.2152.1309.2422.1576.4861.3
Market cap164.2256.7204.1150.6113.8189.2244.6
Enterprise value163.8234.0194.2142.2---
EV/S4,310.1------
EV/EBITDAneg.neg.neg.neg.---
EV/EBITneg.neg.neg.neg.---
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B17.619.3051.7126.0525.98-31.80-46.39
P/S4,320.9---1,422.344.8107.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio54.5 %56.9 %16.0 %23.6 %23.8 %-24.0 %-18.2 %
Gearing ratio-39.5 %-----